Contents

Current Radiopharmaceuticals, Volume 6 - Number 1

Editorial

Editorial

, 6(1): 1 - 6

Sean L. Kitson


DOI: 10.2174/1874471011306010001




Sodium-Proton Exchanger Isoform-1: Synthesis of a Potent Inhibitor Labeled with Deuterium and Carbon-14

, 6(1): 7 - 11

Bachir Latli, Nizar Haddad, Matt Hrapchak, Xudong Wei, Wenjun Tang, Jinhua J. Song and Chris H. Senanayake


DOI: 10.2174/1874471011306010002




Synthesis and Evaluation of 99mTc Chelate-conjugated Bevacizumab

, 6(1): 12 - 19

Ximena Camacho, Maria Fernanda Garcia, Victoria Calzada, Marcelo Fernandez, Williams Porcal, Omar Alonso, Juan Pablo Gambini and Pablo Cabral


DOI: 10.2174/1874471011306010003




Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

, 6(1): 20 - 27

Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle


DOI: 10.2174/1874471011306010004




A Novel 99mTc-labeled Diphosphonic Acid as Potential Bone Seeking Agent: Synthesis and Biological Evaluation

, 6(1): 28 - 35

Ling Qiu, Wen Cheng, Jianguo Lin, Shu Zhang and Shineng Luo


DOI: 10.2174/1874471011306010005




Peptide Imaging with Somatostatin Analogues: More than Cancer Probes

, 6(1): 36 - 40

Giuseppe Lucio Cascini, Vincenzo Cuccurullo, Oscar Tamburrini, Antonio Rotondo and Luigi Mansi


DOI: 10.2174/1874471011306010006




Bone Metastases Radiopharmaceuticals: An Overview

, 6(1): 41 - 47

Vincenzo Cuccurullo, Giuseppe Lucio Cascini, Oscar Tamburrini, Antonio Rotondo and Luigi Mansi


DOI: 10.2174/1874471011306010007




Some Implications of Receptor Kinase Signaling Pathway for Development of Multitargeted Kinase Inhibitors

, 6(1): 48 - 55

Petar M. Mitrasinovic


DOI: 10.2174/1874471011306010008




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science